Study Summary
This trial will test if 4 weeks of sympathetic nerve activity inhibition can reduce circulating blood concentrations and expression of inflammatory markers.
Eligible Conditions
- Obesity
- Insulin Resistance
- Diabetes
- High Blood Pressure
- Sympathetic Nerve Activity
- Diuretic Drug Reactions
Treatment Effectiveness
Effectiveness Progress
Study Objectives
3 Primary · 0 Secondary · Reporting Duration: 4 Week
4 Week
Adipose Tissue Sample: Efficacy of 4-week supply of Clonidine Compared VS 4-week supply of control condition using hydrochlorothiazide (HCTZ) and a separate placebo treatment
Clonidine
Clonidine
Trial Safety
Safety Progress
Trial Design
3 Treatment Groups
Clonidine
1 of 3
Hydrochlorothiazide (HCTZ)
1 of 3
Placebo
1 of 3
Experimental Treatment
Non-Treatment Group
60 Total Participants · 3 Treatment Groups
Primary Treatment: Clonidine Pill · Has Placebo Group · Phase 1
Clonidine
Drug
Experimental Group · 1 Intervention: Clonidine Pill · Intervention Types: DrugHydrochlorothiazide (HCTZ)
Drug
Experimental Group · 1 Intervention: Hydrochlorothiazide 12.5Mg Tab · Intervention Types: DrugPlacebo
Drug
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: DrugTrial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 4 week
Who is running the clinical trial?
University of Kansas Medical CenterLead Sponsor
403 Previous Clinical Trials
158,843 Total Patients Enrolled
16 Trials studying Obesity
102,885 Patients Enrolled for Obesity
Seth W. W Holwerda, PhDPrincipal InvestigatorUniversity of Kansas Medical Center
1 Previous Clinical Trials
46 Total Patients Enrolled
Eligibility Criteria
Age 18 - 79 · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:on two occasions
A person has diabetes if their fasting glucose level is 126 mg/dL or more on two occasions.
You are a male or female, 18-79 years old.
A person who has high blood pressure is called hypertensive
You have insulin resistance.\n
If your waist circ is more than 102 cm (men) or 88 cm (women), you are at a higher risk for developing heart disease and other health problems.
Who else is applying?
What state do they live in?
| Missouri | 66.7% |
| Kansas | 33.3% |
How old are they?
| 18 - 65 | 66.7% |
| 65+ | 33.3% |
What site did they apply to?
| University of Kansas Medical Center | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 66.7% |
| Did not meet criteria | 33.3% |
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments